Factors affecting anxiety, depression, and self-care ability in patients who have undergone liver transplantation

Table 2 Clinical characteristics of the study group associated with liver transplantation

Parameters	n	%
Underlying liver disease
HBV	157	49.7
Cryptogenic	25	7.9
HCC	32	10.1
Wilson	15	4.7
HCV	19	6.0
Autoimmune	22	6.9
Others	46	14.5
Type of LT
LDLT	291	92.1
DDLT	25	7.9
Biliary complications
Presence	200	63.3
Absence	116	36.7
Antiviral agents use (HBV/HCV)
Yes	196	62.0
No	120	38.0
Ursodeoxycholic use
Yes	229	72.5
No	87	27.5
Tacrolimus use
Yes	286	90.5
No	30	9.5
Everolimus use
Yes	108	34.2
No	208	65.8
Corticosteroid use
Yes	96	30.4
No	220	69.6
Mycophenolate mofetil use
Yes	212	67.1
No	104	32.9
PPI Inhibitors use
Yes	314	99.4
No	2	0.6
Inclination towards recommendation of LT to others
I recommend	285	90.2
I do not recommend	31	9.8
Frequency of out-patient visits
Monthly	264	83.5
Quarterly	52	16.5

DDLT: Deceased donor liver transplantation; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; LDLT: Living donor liver transplantation; LT: Liver transplantation.